300026.SZ · 红日药业
China A-shares · RS rating 72 · As of 2026-10-14
| Price | 3.25 CNY |
|---|---|
| 1-day change | -0.6% |
| RS rating (overall / 1M / 3M / 12M) | 72 / 72 / 63 / 52 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 42 / 29 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -6.4% |
| Distance from 52-week high | +17.7% |
| Market cap (USD) | $1.5B |